EUVIMEDEUVIMED entdecken
Leserbrief

Valuing Public Sector Data Assets: Methodological Perspectives From the Add-Aspirin Trial’s Use of Healthcare Systems Data for Clinical Follow-Up

K Shu, M Cheng

Clinical Oncology · 2026-08 · 56 · 104162

DOI: 10.1016/j.clon.2026.104162 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Oncology, 2026-08. Verfasst von K Shu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Tongling University, China. Die Arbeit nennt 4 Literaturangaben. Gefördert von: Anhui Provincial Department of Education.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Tongling University, China.
  • Anhui Vocational and Technical University, China. Electronic address: chengmengting@gou.edu.pl.

Förderung

  • Anhui Provincial Department of Education

Zitieren

APA

Shu, K., & Cheng, M. (2026). Valuing Public Sector Data Assets: Methodological Perspectives From the Add-Aspirin Trial’s Use of Healthcare Systems Data for Clinical Follow-Up. Clinical Oncology, 56, 104162. https://doi.org/10.1016/j.clon.2026.104162

Vancouver

Shu K, Cheng M. Valuing Public Sector Data Assets: Methodological Perspectives From the Add-Aspirin Trial’s Use of Healthcare Systems Data for Clinical Follow-Up. Clinical Oncology. 2026;56:104162. doi:10.1016/j.clon.2026.104162

BibTeX
@article{Shu2026,
  author = {Shu, K and Cheng, M},
  title = {Valuing Public Sector Data Assets: Methodological Perspectives From the Add-Aspirin Trial’s Use of Healthcare Systems Data for Clinical Follow-Up},
  journal = {Clinical Oncology},
  year = {2026},
  volume = {56},
  pages = {104162},
  doi = {10.1016/j.clon.2026.104162}
}
Kostenlos starten →